Gagliardi G M, Rossi S, Manes M T, Gerace G, Martire V, Caruso F, Vocaturo G, De Napoli N
U.O. di Nefrologia, Dialisi e Trapianto, Azienda Ospedaliera di Cosenza, Cosenza.
G Ital Nefrol. 2004 Jan-Feb;21(1):45-50.
Left ventricular hypertrophy is the main manifestation of uraemic cardiomyopathy and predicts both cardiovascular events and death independently of conventional risk factors. Diastolic dysfunction is often associated with left ventricular hypertrophy, and accounts for up to 30% of heart failure. The aim of this study was to estimate the impact and the prevalence of left ventricular hypertrophy, its geometric models and diastolic dysfunction on haemodialysis patients, as well as the relationship with cardiac troponin, a specific marker for myocardial damage.
We enrolled in the study 31 patients (26 on haemodialysis, 5 on peritoneal dialysis) and 31 normal healthy subjects as the control group. Echocardiographic measurements were carried out according to the recommendations of the American Society of Echocardiography. Left ventricular mass was calculated according to the Devereux formula and indexed to height 2.7 We carried out Doppler echocardiography to study the diastolic function by measurements of isovolumic relaxation period (IVRT), E-wave deceleration time (DTE) and E/A ratio. We measured cardiac troponin using a third generation electrochemiluminescence immunoassay. We did the statistical analysis with the t test for comparison among groups, and we established correlations using the Pearson and Spearman correlation test. We considered values of p<0.05 to be statistically significant.
Eccentric hypertrophy was the most frequent pattern (n=17; 55%), followed by normal cardiac geometry (n=7; 23%) and concentric hypertrophy (n=5; 16%). Only a minority of patients (n=2; 6%) showed concentric remodelling. Systolic dysfunction was present in 3 patients (EF<50%). Diastolic dysfunction was present in 24 out of 31 HD patients, that had abnormal relaxation pattern, characterised by prolonged IVRT, prolonged DTE and E/A ratio <1. Only one patient had restrictive filling pattern with reduced DTE and E/A ratio >2. Fourteen patients (45%) had E/A ratio < or =0.5, 10 patients (32%) had E/A ratio >0.5<1 and 7 patients (13%) had E/A ratio > or =1. DTE was prolonged in 14 patients (45%) and IVRT was prolonged in 6 patients (19%). The patients with E/A ratio < or =0.5 (n=14; 45%) suffered major hypotensive episodes during dialytic sessions compared to patients with E/A ratio >0.5, we found this difference to be statistically significant (p < 0.01). We observed the E/A ratio to be negatively correlated with age (r = -0.41; p=0.02) whereas DTE was positively correlated with posterior wall thickness (r =0.36; p= 0.05) and interventricular septum thickness (r =0.45; p=0.01). Cardiac troponin was positively correlated with age (r =0.50; p=0.00), left ventricular mass (r =0.41; p=0.02), posterior wall thickness (r =0.41; p=0.02) and interventricular septum thickness (r =0.39; p=0.03) but not with diastolic dysfunction parameters. Serum cardiac troponin was elevated (> or =0.10 micro g/L) in 12 patients (38.7%) and was associated with eccentric hypertrophy in all the cases. We detected no significant differences among groups with normal left ventricular geometry and left ventricular hypertrophy in the duration of the dialytic treatment, but we noted a statistically significant difference in relationship to age (p=0.03).
Left ventricular hypertrophy is associated with diastolic dysfunction, both cause of hypotensive episodes during dialytic treatments and heart failure in patients with normal systolic function. The non invasive assessment of left ventricular diastolic function would represent an important advancement in the diagnosis and prevention of heart failure in haemodialysis patients.
左心室肥厚是尿毒症性心肌病的主要表现,可独立于传统危险因素预测心血管事件和死亡。舒张功能障碍常与左心室肥厚相关,占心力衰竭病例的30%。本研究旨在评估左心室肥厚及其几何模型和舒张功能障碍对血液透析患者的影响和患病率,以及与心肌损伤特异性标志物心肌肌钙蛋白的关系。
我们招募了31例患者(26例接受血液透析,5例接受腹膜透析)和31名正常健康受试者作为对照组。根据美国超声心动图学会的建议进行超声心动图测量。左心室质量根据Devereux公式计算,并根据身高进行指数化处理。我们进行多普勒超声心动图检查,通过测量等容舒张期(IVRT)、E波减速时间(DTE)和E/A比值来研究舒张功能。我们使用第三代电化学发光免疫分析法测量心肌肌钙蛋白。我们采用t检验进行组间比较的统计分析,并使用Pearson和Spearman相关检验建立相关性。我们认为p<0.05的值具有统计学意义。
离心性肥厚是最常见的类型(n = 17;55%),其次是正常心脏几何形态(n = 7;23%)和向心性肥厚(n = 5;16%)。只有少数患者(n = 2;6%)表现为向心性重构。3例患者存在收缩功能障碍(射血分数<50%)。31例血液透析患者中有24例存在舒张功能障碍,其舒张模式异常,表现为IVRT延长、DTE延长和E/A比值<1。只有1例患者具有限制性充盈模式,DTE缩短且E/A比值>2。14例患者(45%)的E/A比值≤0.5,10例患者(32%)的E/A比值>0.5<1,7例患者(13%)的E/A比值≥1。14例患者(45%)的DTE延长,6例患者(19%)的IVRT延长。与E/A比值>0.5的患者相比,E/A比值≤0.5的患者(n = 14;45%)在透析过程中发生严重低血压发作,我们发现这种差异具有统计学意义(p < 0.01)。我们观察到E/A比值与年龄呈负相关(r = -0.41;p = 0.02),而DTE与后壁厚度呈正相关(r = 0.36;p = 0.05)和室间隔厚度呈正相关(r = 0.45;p = 0.01)。心肌肌钙蛋白与年龄呈正相关(r = 0.50;p = 0.00)、左心室质量呈正相关(r = 0.41;p = 0.02)、后壁厚度呈正相关(r = 0.41;p = 0.02)和室间隔厚度呈正相关(r = 0.39;p = 0.03),但与舒张功能障碍参数无关。12例患者(38.7%)的血清心肌肌钙蛋白升高(≥0.10 μg/L),且在所有病例中均与离心性肥厚相关。我们发现左心室几何形态正常和左心室肥厚的组间在透析治疗时间上无显著差异,但在年龄方面存在统计学显著差异(p = 0.03)。
左心室肥厚与舒张功能障碍相关,这既是透析治疗期间低血压发作的原因,也是收缩功能正常患者发生心力衰竭的原因。左心室舒张功能的无创评估将是血液透析患者心力衰竭诊断和预防方面的一项重要进展。